Abstract
BackgroundNo standard therapies beyond first line are established for advanced squamous cell anal carcinoma (aSCAC). Earlier preliminary data suggest activity of epidermal growth factor receptor (EGFR) inhibition and programmed cell...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have